EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proceedings of the inaugural symposium on dengue human challenge studies “Challenging the norm: Accelerating dengue countermeasures through human studies”

Shirin Kalimuddin iD, Adam T Waickman, Panisadee Avirutnan, Mohammad Shafiul Alam, Christopher Chiu, Barnaby E Young, Christopher W Woods, Petra C Fay, Sheila K Pakir, Jo-Anne Manski-Nankervis, Claus Bolte, Andrew Pengilley und 5 weitere

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0013889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Shirin Kalimuddin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Dengue, Dengue Vaccines, Dengue Virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Global Dengue and Aedes-Transmitted Diseases Consortium, National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On 12th June 2025, Duke-NUS Medical School, supported by the Global Dengue and Aedes -Transmitted Diseases Consortium (GDAC), hosted a one-day symposium in Singapore titled “Challenging the norm: Accelerating dengue countermeasures through human challenge studies”. Comprising sessions on both dengue and other viral infection models, the symposium explored how human challenge studies could address gaps in dengue pathogenesis and immunity to inform vaccine development and application. Keynote speakers highlighted persistent challenges in dengue vaccine development, including incomplete protection across all four dengue viruses, complexities in dengue immunity, and past safety concerns that have influenced regulatory pathways. Case studies from Thailand and Bangladesh illustrated the feasibility and safety of dengue challenge studies in endemic settings. Parallel discussions drew lessons from human infection models of SARS-CoV-2 and other respiratory viruses that are directly relevant to expanding the use of dengue human challenge studies. Sessions on public engagement and regulatory frameworks emphasised the importance of trust, transparent communication, and harmonisation in the design, conduct, and acceptance of challenge studies. Overall, the symposium highlighted that human challenge studies, if implemented thoughtfully, can advance dengue vaccine research, accelerate clinical evaluation and regulatory approval of vaccine candidates, and support evidence-based public health strategies to strengthen global dengue control efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueDengue VaccinesDengue VirusHumansVaccine DevelopmentAnimalsCOVID-19SARS-CoV-2Singapore

Substanzen

Dengue Vaccines

Autor:innen und Institutionen

  • Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
  • Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, United States of America.
  • Upstate Global Health Institute, State University of New York Upstate Medical University, Syracuse, New York, United States of America.
  • Division of Dengue Hemorrhagic Fever Research and Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.

ORCID-Profile: Shirin Kalimuddin

Förderung

  • Global Dengue and Aedes-Transmitted Diseases Consortium
  • National Medical Research Council

Zitieren

APA

Kalimuddin, S., Waickman, A. T., Avirutnan, P., Alam, M. S., Chiu, C., Young, B. E., Woods, C. W., Fay, P. C., Pakir, S. K., Manski-Nankervis, J. A., Bolte, C., Pengilley, A., Cavaleri, M., Lim, J. C. W., Thomas, S. J., Ko, A. I., & Ooi, E. E. (2026). Proceedings of the inaugural symposium on dengue human challenge studies “Challenging the norm: Accelerating dengue countermeasures through human studies”. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013889

Vancouver

Kalimuddin S, Waickman AT, Avirutnan P, Alam MS, Chiu C, Young BE, et al. Proceedings of the inaugural symposium on dengue human challenge studies “Challenging the norm: Accelerating dengue countermeasures through human studies”. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0013889

BibTeX
@article{Kalimuddin2026,
  author = {Kalimuddin, Shirin and Waickman, Adam T and Avirutnan, Panisadee and Alam, Mohammad Shafiul and Chiu, Christopher and Young, Barnaby E and Woods, Christopher W and Fay, Petra C and Pakir, Sheila K and Manski-Nankervis, Jo-Anne and Bolte, Claus and Pengilley, Andrew and Cavaleri, Marco and Lim, John C W and Thomas, Stephen J and Ko, Albert I and Ooi, Eng Eong},
  title = {Proceedings of the inaugural symposium on dengue human challenge studies “Challenging the norm: Accelerating dengue countermeasures through human studies”},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0013889}
}
Kostenlos starten →